U.S. Markets closed

Eli Lilly CEO Says Drug Pricing Innovation Is Needed

Jan.09 -- David Ricks, chairman and chief executive officer at Eli Lilly & Co., discusses drug pricing and shifting industry dynamics. He speaks with Erik Schatzker on "Bloomberg Markets" from the JPMorgan Healthcare Conference in San Francisco.